Journal article · 2011 · Open access
Adverse drug reaction and causality assessment scales
Lung India, 28(2), 152 · Published 1 January 2011 · DOI 10.4103/0970-2113.80343
In brief
“Adverse drug reaction and causality assessment scales” is a 2011 journal article by SyedAhmed Zaki, published in Lung India. OpenAlex counts 143 citations as of 15 November 2026, which puts it in the top 7% of works published in 2011 by citations. It is open access under a CC BY-NC-SA licence: the full text is free to read at Lung India.
- Citations
- 143
- Most cited in
- 2019 (24)
- Field-weighted impact
- 3.91
- References
- 3
- Authors
- 1
Abstract
Sir, I read with interest the articles by Gupta et al and Gulati et al on adverse drug reactions of antituberculous drugs.[12] I would like to make the following comments. Adverse drug reactions (ADRs) are a major cause of morbidity, hospital admission, and even death. Hence it is essential to recognise ADRs and to establish a causal relationship between the drug and the adverse event. It is desirable that ADRs should be objectively assessed and presented based on an acceptable “Probability Scale.” Many causality methods have been proposed to assess the relationship between a drug and an adverse event in a given patient, ranging from short questionnaires to comprehensive algorithms. The idea of creating a standardized assessment for the relationship-likelihood of case reports of suspected ADRs was in the hope that this would, in a structured way, lead to a reliable reproducible measurement of causality. The causality assessment system proposed by the World Health Organization Collaborating Centre for International Drug Monitoring, the Uppsala Monitoring Centre (WHO–UMC), and the Naranjo Probability Scale are the generally accepted and most widely used methods for causality assessment in clinical practice as they offer a simple methodology.[34] The above scales are structured, transparent, consistent, and easy to apply assessment methods. Table 1 summarizes the “Naranjo ADR Probability Scale,” which has gained popularity among clinicians because of its simplicity.[3] The WHO–UMC causality system takes into account the clinical-pharmacologic aspects, whereas previous knowledge of the ADR plays a less prominent role. Table 2 summarizes the WHO–UMC Probability Scale.[4]Table 1: Naranjo ADR probability scale—items and scoreTable 2: WHO–UMC causality categoriesI humbly request the Editors that Lung India should use either of the above two scales while reviewing articles related to ADRs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zaki, S. (2011). Adverse drug reaction and causality assessment scales. Lung India, 28(2), 152. https://doi.org/10.4103/0970-2113.80343
MLA 9
Zaki, SyedAhmed. “Adverse drug reaction and causality assessment scales.” Lung India, vol. 28, no. 2, 2011, p. 152. https://doi.org/10.4103/0970-2113.80343.
Chicago
Zaki, SyedAhmed. 2011. “Adverse drug reaction and causality assessment scales.” Lung India 28 (2): 152. https://doi.org/10.4103/0970-2113.80343.
Harvard
Zaki, S. (2011) ‘Adverse drug reaction and causality assessment scales’, Lung India, 28(2), p. 152. doi:10.4103/0970-2113.80343.
IEEE
S. Zaki, “Adverse drug reaction and causality assessment scales,” Lung India, vol. 28, no. 2, p. 152, 2011, doi: 10.4103/0970-2113.80343.
BibTeX
@article{zaki2011adverse,
title = {{Adverse drug reaction and causality assessment scales}},
author = {Zaki, SyedAhmed},
journal = {Lung India},
year = {2011},
volume = {28},
number = {2},
pages = {152},
doi = {10.4103/0970-2113.80343},
url = {https://doi.org/10.4103/0970-2113.80343}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 10 | |
| 2018 | 16 | |
| 2019 | 24 | |
| 2020 | 12 | |
| 2021 | 19 | |
| 2022 | 9 | |
| 2023 | 7 | |
| 2024 | 7 | |
| 2025 | 6 | |
| 2026 | 4 |
Its field-weighted citation impact is 3.91: it has been cited 3.91 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- adverse drug reactions
- antitubercular agents
- causality assessment
- Naranjo probability scale
- WHO-UMC causality assessment
- drug safety
- tuberculosis
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Zaki, S. (2011). Adverse drug reaction and causality assessment scales. Lung India, 28(2), 152. https://doi.org/10.4103/0970-2113.80343
How many times has this paper been cited?
143 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Lung India.
Who wrote this paper?
SyedAhmed Zaki.
What is the DOI of this paper?
10.4103/0970-2113.80343. The permanent link is https://doi.org/10.4103/0970-2113.80343.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.